THRIVE

Welcome to the Brand page for “THRIVE”, which is offered here for Preparations for use in the treatment of autosomal dominant disorders; preparations for use in the treatment of amyotrophic lateral sclerosis (als); preparations for use in the treatment of alpha-1 antitrypsin deficiency;.

Its status is currently believed to be active. Its class is unavailable. “THRIVE” is believed to be currently owned by “Apic Bio, Inc.”


Owner:
APIC BIO, INC.
Owner Details
Description:
Preparations for use in the treatment of autosomal dominant disorders; preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); preparations for use in the treatment of Alpha-1 Antitrypsin Deficiency;
Categories: PREPARATIONS USE